CLSep 18, 2024

Development and bilingual evaluation of Japanese medical large language model within reasonably low computational resources

arXiv:2409.11783v23 citationsh-index: 4Has Code
Originality Incremental advance
AI Analysis

This work addresses the financial and security barriers for clinical institutions to use LLMs locally, though it is incremental as it adapts existing models.

The authors tackled the high computational cost of deploying large language models in healthcare by developing a 7B-parameter medical LLM that operates with low resources, achieving performance on medical QA benchmarks in Japanese and English that matches or exceeds models ten times larger.

The recent success of large language models (LLMs) and the scaling law has led to a widespread adoption of larger models. Particularly in the healthcare industry, there is an increasing demand for locally operated LLMs due to security concerns. However, the majority of high quality open-source LLMs have a size of 70B parameters, imposing significant financial burdens on users for GPU preparation and operation. To overcome these issues, we present a medical adaptation based on the recent 7B models, which enables the operation in low computational resources. We compare the performance on medical question-answering benchmarks in two languages (Japanese and English), demonstrating that its scores reach parity with or surpass those of currently existing medical LLMs that are ten times larger. We find that fine-tuning an English-centric base model on Japanese medical dataset improves the score in both language, supporting the effect of cross-lingual knowledge transfer. We hope that this study will alleviate financial challenges, serving as a stepping stone for clinical institutions to practically utilize LLMs locally. Our evaluation code is available at https://github.com/stardust-coder/japanese-lm-med-harness.

Code Implementations1 repo
Foundations

The foundational work for this paper's niche, ranked by how specifically the neighbourhood builds on it — not by global fame.

Your Notes